Doctor Shigemasa Tani
Nihon University Hospital, Tokyo (Japan)
The ratio of eicosapentaenoic acid (EPA) to arachidonic acid may be a residual risk marker in stable coronary artery disease patients receiving treatment with statin following EPA therapy
Event: ESC Congress 2016
Topic: Adjunctive medical therapy
Session: Adjunctive medical therapy in coronary artery disease
